Xuebin Liao

17PUBLICATIONS
39CO-AUTHORS
Medical devicesMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Disease surveillanceCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 25, 2026
Rational Design and Identification of Highly Selective TLR8 Agonists as Potent HIV-1 Latency Reversal Agents.

Zhisong Wang, Yangyang Li, Jie Wang

|Apr 23, 2024
Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress.

Hui Chen, Xiangna Guan, Chi He

|Mar 09, 2024
Mi-2β promotes immune evasion in melanoma by activating EZH2 methylation.

Cang Li, Zhengyu Wang, Licheng Yao

|Nov 03, 2021
Immune Modulating Antibody-Drug Conjugate (IM-ADC) for Cancer Immunotherapy.

Lei He, Liangliang Wang, Zhisong Wang

|May 28, 2021
Structure-Based Design of Highly Potent Toll-like Receptor 7/8 Dual Agonists for Cancer Immunotherapy.

Zhisong Wang, Yan Gao, Lei He

Pageof 3